Heart Disease News and Research

Latest Heart Disease News and Research

Too much weight in pregnancy may lead to future heart risks in offspring

Researchers have uncovered evidence to show that piling on too many pounds in pregnancy may lead to future heart risks in the child.

4 Jun 2010

Cardinal Health and UW collaborate to advance use of molecular imaging in clinical investigations and trials

Cardinal Health and the University of Washington (UW) today announced an innovative public-private collaboration designed to advance the use of molecular imaging in clinical investigations and trials.

4 Jun 2010

Bayer to present Phase I and II clinical trial data of Alpharadin in CRPC at 46th ASCO

Bayer HealthCare will present a combined analysis from Phase I and II clinical trials evaluating the safety and efficacy of one of its lead investigational cancer treatments, Alpharadin™ (radium-223 chloride), in castration-resistant prostate cancer (CRPC) that has spread to the bones (metastases).

4 Jun 2010

Nile Therapeutics receives Nasdaq non-compliance notice

Nile Therapeutics, Inc., a company focused on the development of novel therapeutics for heart failure patients, today announced that, on June 1, 2010, the Company received a letter from The Nasdaq Stock Market indicating that the minimum closing bid price of its common stock had fallen below $1.00 for 30 consecutive trading days, and therefore, Nile was not in compliance with Marketplace Rule 5550(a)(2).

4 Jun 2010

Earliest blood flow begins all at once

By capturing movies of both the blood and vasculature of zebrafish embryos, each less than two millimeters long, researchers have been able for the first time to see the very moment that blood begins to flow.

4 Jun 2010

Antiemetic-regimen with fosaprepitant injection provides similar protection against CINV as oral EMEND

Merck announced today results from a new non-inferiority trial of an antiemetic regimen containing fosaprepitant dimeglumine administered as a single intravenous (IV) 150-mg dose in combination with a 5-HT3 antagonist and dexamethasone compared with a three-day regimen of aprepitant with a 5-HT3 antagonist and dexamethasone for the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving a first cycle of cisplatin-based chemotherapy.

4 Jun 2010

Freescale Semiconductor develops portable medical kiosk to run routine health screenings at home

As the population continues to age and medical monitoring becomes more integrated into everyday living, healthcare professionals are constantly striving to find new ways to monitor patients with improved accuracy, speed and end-user convenience. Taking an active part in this initiative, Freescale Semiconductor, partnering with Pounce Consulting, developed a portable, easy-to-use telemonitoring reference design, which allows patients and physicians to run routine health screenings at home or remotely.

4 Jun 2010

Promising results of ABRAXANE for bladder cancer support efficacy of nab-driven chemotherapy

Abraxis BioScience, Inc. announced today that findings from a phase 1 randomized trial demonstrated that the nanoparticle albumin bound (nab®) driven chemotherapy, nab-paclitaxel (ABRAXANE® for Injectable Suspension; paclitaxel albumin protein-bound particles for injectable suspension) is well-tolerated and active in the second-line treatment of high-grade, non-muscle-invasive bladder cancer that has been refractory to standard intra-bladder infusion (intravesical) therapy.

4 Jun 2010

Masimo SET pulse oximetry screening effective for early diagnosis of critical CHD in newborns

Masimo, the inventor of Pulse CO-Oximetry™ and Measure-Through Motion and Low Perfusion pulse oximetry, announced today that a new clinical study published online in the German pediatric journal, Klinische Padiatrie, showed that adding Masimo SET pulse oximetry screening to the physical examination of newborns was an effective method to achieve early diagnosis of critical congenital heart disease (CHD).

4 Jun 2010

Lovastatin protects animals against plague

An experimental study has revealed that lovastatin, a drug prescribed for the treatment of hypercholesterolemia, protects animals against the deadly effects of plague. This infectious disease is on the upsurge in parts of the world. These results obtained by scientists at the Unité de Recherche sur les Maladies Infectieuses et Tropicales Emergentes (CNRS/Université Aix-Marseille 2) have been published in the journal PLoS ONE.

4 Jun 2010

Advanced applications of Nanoflex technology to be presented at New Cardiovascular Horizons Meeting

ULURU Inc. announced today that advanced applications of the Nanoflex technology, related to future products in drug delivery and tissue engineering, will be presented at the 11th annual New Cardiovascular Horizons Meeting to be held in New Orleans, Louisiana on June 2-5, 2010. This meeting is the largest medical meeting that focuses on peripheral artery disease and peripheral interventions, including wound care for vascular ulcers, the application of advanced therapies for limb salvage and amputation prevention.

4 Jun 2010

Ongoing clinical development program for NX-1207 for treatment of BPH highlighted

Nymox Pharmaceutical Corporation is pleased to report on the presentation of new positive data at a high-level symposium and panel discussion held at the Annual Meeting of the American Urological Association in San Francisco. The symposium was held between 6:00 and 7:00 pm EDT on Tuesday. The well-attended symposium highlighted the ongoing clinical development program for NX-1207 for the treatment of benign prostatic hyperplasia and featured expert panel discussions on the new therapy.

4 Jun 2010

Key regulator of fat cell differentiation identified

New research led by UCD Conway Fellow, Professor Johan Ericsson has identified a key regulator of fat cell differentiation that may be a novel target for obesity drugs. The results of the research are published in the current edition of the scientific journal, Proceedings of the National Academy of Sciences (PNAS).

4 Jun 2010

EPIC Imaging Centers improves practice management services with MedInformatix RIS

As the largest and most technologically advanced outpatient imaging facility in the Portland metro area, EPIC Imaging Centers serves 120,000 patients a year with full-service MRI, PET/CT scanning, x-ray, ultrasound, mammography and other advanced imaging services. Always on the cutting edge, the company recently became home to the first stand-up MRI system in Oregon, providing thousands of patients with a more flexible option for achieving the most effective images to treat pain and other conditions.

4 Jun 2010

Quality of life improves treatment of children with velocardiofacial syndrome: Research

Research about quality of life is improving the treatment of children with velocardiofacial syndrome, a chronic, genetic condition with a wide range of symptoms, including congenital heart disease, palatal abnormalities (e.g. cleft palate), and learning difficulties.

4 Jun 2010

ELLICSR research centre opened at UHN

What do you get when you combine a comedian, a magician, a radio show host, and a chef? A group of cancer survivors and caregivers celebrating National Cancer Survivors Day at the opening of a unique new research centre at University Health Network (UHN), the first of its kind in Canada.

4 Jun 2010

State roundup: Health law could be critical for Miss.'s poor; Colorado passes end-of-life care laws, Penn. details plan for high risk pool

The health care overhaul, which "provides hundreds of billions of dollars to help states expand medical insurance for the poor," could prove critical for Mississippi, which "has the highest poverty rate in the nation and some of the sickest people, with the country's highest rate of heart disease and the second-highest rate of diabetes.

4 Jun 2010

New UNC-Olympus Research Imaging Center opens doors

The University of North Carolina (UNC) at Chapel Hill today opened the doors of a new facility designed to be one of the world's most sophisticated research centers devoted to life science imaging. The new UNC-Olympus Research Imaging Center provides researchers with advanced microscopes and camera equipment, software, consultation and expertise, in an environment intended to encourage the highest levels of scientific inquiry.

From Evident Corporation - Life Sciences 4 Jun 2010

Royal Philips Electronics, RXi Pharmaceuticals sign joint research agreement

Royal Philips Electronics and RXi Pharmaceuticals Corporation, a US-based biopharmaceutical company, today announced that they have entered into a joint research agreement to explore the benefits of combining proprietary technologies from both companies for the targeted delivery of experimental therapeutics based on RNA interference.

4 Jun 2010

SERCA2a gene therapy proves effective in people with advanced heart failure: Researchers

Researchers at Mount Sinai School of Medicine have developed a new gene therapy that is safe and effective in reversing advanced heart failure. SERCA2a (produced as MYDICAR-) is a gene therapy designed to stimulate production of an enzyme that enables the failing heart to pump more effectively.

4 Jun 2010

Heart Disease News and Research

Latest Heart Disease News and Research

Too much weight in pregnancy may lead to future heart risks in offspring

Cardinal Health and UW collaborate to advance use of molecular imaging in clinical investigations and trials

Bayer to present Phase I and II clinical trial data of Alpharadin in CRPC at 46th ASCO

Nile Therapeutics receives Nasdaq non-compliance notice

Earliest blood flow begins all at once

Antiemetic-regimen with fosaprepitant injection provides similar protection against CINV as oral EMEND

Freescale Semiconductor develops portable medical kiosk to run routine health screenings at home

Promising results of ABRAXANE for bladder cancer support efficacy of nab-driven chemotherapy

Masimo SET pulse oximetry screening effective for early diagnosis of critical CHD in newborns

Lovastatin protects animals against plague

Advanced applications of Nanoflex technology to be presented at New Cardiovascular Horizons Meeting

Ongoing clinical development program for NX-1207 for treatment of BPH highlighted

Key regulator of fat cell differentiation identified

EPIC Imaging Centers improves practice management services with MedInformatix RIS

Quality of life improves treatment of children with velocardiofacial syndrome: Research

ELLICSR research centre opened at UHN

State roundup: Health law could be critical for Miss.'s poor; Colorado passes end-of-life care laws, Penn. details plan for high risk pool

New UNC-Olympus Research Imaging Center opens doors

Royal Philips Electronics, RXi Pharmaceuticals sign joint research agreement

SERCA2a gene therapy proves effective in people with advanced heart failure: Researchers

How industrial hygiene flow calibration supports defensible exposure data

How electrical engineering ensures accurate calibration and patient safety

The importance of ketones from a clinical and medical perspective

Heart Disease News and Research

Latest Heart Disease News and Research

How industrial hygiene flow calibration supports defensible exposure data

How electrical engineering ensures accurate calibration and patient safety

The importance of ketones from a clinical and medical perspective

Newsletters you may be interested in